SIOC 中文
ACS
Adv search

Acta Chimica Sinica >

2012 , Vol. 70 >Issue 22: 2372 - 2376

DOI: https://doi.org/10.6023/A12080509

Article

A New Dual Immunoassay for the Determination of α-Fetoprotein and Carcinoembryonic Antigen Based on Chemiluminescence Signal Amplification by Functional Graphite Oxide

  • Lin Jiehua ,
  • Zhang Huihui ,
  • Chu Pengfei
Expand
  • College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao 266042

Received date: 2012-08-05

  Online published: 2012-10-25

Supported by

Project supported by the National Natural Science Foundation of China (No. 20905041), and the Doctoral Foundation of Shandong Province (No. BS2011SW008).

Fold

Abstract

A sensitive dual immunoassay was proposed for the determination of carcinoembryonic antigen (CEA) and α-fetoprotein (AFP) based on signal amplification. Monoclonal antibodies of AFP and CEA were immobilized on magnetic mesoporous silica particles (Fe3O4/SiO2) respectively and prepared as the primary probe (AFP-Ab1/Fe3O4/SiO2 and CEA-Ab1/Fe3O4/SiO2). In order to improve the detection sensitivity, the current work was focused on the signal amplification by using increased amount of horseradish peroxidase (HRP). Graphite oxide (GO) with functioned carboxyl groups were used to immobilize the HRP labeled antibodies to prepare the secondary probes (AFP-HRP-Ab2/GO and CEA-HRP-Ab2/GO). The enhanced signals were attributed to a high HRP-tag molar ratio on the surface of GO. Two subminiature quartz flow cells were set upon the photomultiplier (PMT) in parallel. As soon as CEA-Ab1/Fe3O4/SiO2 and AFP-Ab1/Fe3O4/SiO2 were injected into the corresponding flow cell, they were adsorbed on the inside walls by the bar magnet. Then, the mixed solutions of CEA, AFP, AFP-HRP-Ab2/GO and CEA-HRP-Ab2/GO were injected into the two flow cells and stopped for 30 min. Based on a sandwich immunoassay format, the HRP tags were retained in the flow cells. Finally, the CL substrates of luminol and H2O2 were controlled to the two parallel flow cells, so the sequential determination of two tumor markers was achieved. Due to the increased amount of HRP on the surface of GO and the increased amount of monoclonal antibodies on Fe3O4/SiO2, the signals were largely amplified. The effects on the dual immunoassay, such as the concentrations of luminol and H2O2, the incubation time, and the pH value of the buffer solution, were investigated in the current work. Under the optimal conditions, typical flow injection CL signals have been obtained with the sandwich multiplexed immunoassay for CEA and AFP. AFP could be detected in the linear ranges 0.005～0.5 and 0.5～100 ng/mL. CEA could be detected in the linear ranges of 0.0025～1.0 and 1.0～80 ng/mL. The detection limits of AFP and CEA were 5.0 and 2.5 pg/mL, respectively. The proposed method was in favor of reducing sample consumption and facilitating the operation.

Key words： chemiluminescent immunoassay; flow injection analysis; graphite oxide; horseradish peroxidase; signal amplification

Cite this article

Lin Jiehua , Zhang Huihui , Chu Pengfei . A New Dual Immunoassay for the Determination of α-Fetoprotein and Carcinoembryonic Antigen Based on Chemiluminescence Signal Amplification by Functional Graphite Oxide[J]. Acta Chimica Sinica, 2012 , 70(22) : 2372 -2376 . DOI: 10.6023/A12080509

References

[1] Yonemori, K.; Ando, M.; Shibata, T.; Katsumata, N.; Matsumoto, K.; Yamanaka, Y.; Kouno, T.; Shimizu, C.; Fujiwara, Y. J. Cancer Res. Clin. Oncol. 2006, 132(10), 635.
[2] Smith, R. A.; Cokkinides, V.; von Eschenbach, A. C.; Levin, B.; Cohen, C.; Runowicz, C. D.; Sener, S.; Saslow, D.; Eyre, H. J. CA Cancer J. Clin. 2002, 52(1), 8.
[3] Li, C. H. Chin. J. Laboratory Med. 2000, 23(1), 6. (李春海, 中华检验医学杂志, 2000, 23(1), 6.)
[4] Sun, X. L.; Chu, J. G.; Chen, P. Z.; Yang, H. Y.; Dai, Y. Labeled Immunoassays and Clinical Medicine 2001, 8(3), 160. (孙晓丽, 褚建国, 陈泮藻, 杨航燕, 戴雨, 标记免疫分析与临床, 2001, 8(3), 160).
[5] Nunez, E. A. Tumor Biol. 1994, 15(2), 63.
[6] Dudich, E.; Semenkova, L.; Gorbatova, E.; Dudich, I.; Khromykh, L.; Tatulov, E.; Grechko, G.; Sukhikh, G. Tumor Biol. 1998, 19(1), 30.
[7] Wang, X. W.; Xie, H. Life Sci. 1999, 4(1), 17.
[8] Li, M. S.; Li, P. F.; He, S. P.; Du, G. G.; Li, G. World J. Gastroenterol. 2002, 8(3), 469.
[9] Castaldi, F.; Marino, M.; Beneduce, L.; Belluco, C.; De Marchi, F.; Mammano, E.; Nitti, D.; Lise, M.; Fassina, G. Int. J. Biol. Markers 2005, 20(4), 204.
[10] Sorbye, H.; Dahl, O. J. Clin. Oncol. 2003, 21(23), 4466.
[11] Zhang, L. M. Basic Clinical Medicine 1995, 15(4), 247. (张丽民, 基础医学与临床, 1995, 15(4), 247.)
[12] Lin, J. H.; Ju, H. X. Biosens. Bioelectron. 2005, 20, 1461.
[13] Zhou, Y.; Zhang, Y. H.; Lau, C. W.; Lu, J. Z. Anal. Chem. 2006, 78, 5920.
[14] Fu, Z. F.; Hao, C.; Fei, X. Q.; Ju, H. X. J. Immunol. Methods 2006, 312, 61.
[15] Bidlingmaier, M.; Suhr, J.; Ernst, A.; Wu, Z.; Keller, A.; Strasburger, C. J.; Bergmann, A. Clin. Chem. 2009, 55(3), 445.
[16] Du, D.; Wang, L. M.; Shao, Y. Y.; Wang, J.; Engelhard, M. H.; Lin, Y. H. Anal. Chem. 2011, 83(3), 746.
[17] Lin, J. H.; Zhang, H.; Mei, Z. H.; Hu, K. C. Chin. J. Anal. Chem. 2010, 38, 924. (林洁华, 张慧, 梅振华, 胡孔诚, 分析化学, 2010, 38, 924.)
[18] Lin, J. H.; Chu, P. F.; Wei, Z. J. Anal. Sci. 2012, 28(1), 21.
[19] Fu, Z. F.; Yang, Z. J.; Tang, J. H.; Liu, H.; Yan, F.; Ju, H. X. Anal. Chem. 2007, 79, 7376.
[20] Xia, Q. F.; Luo, D.; Li, Z. J. Acta Chim. Sinica 2012, 70, 2079. (夏前芳, 罗丹, 李在均, 化学学报, 2012, 70, 2079.)
[21] Lin, J. H.; Wei, Z. J.; Mao, C. M. Biosens. Bioelectron. 2011, 29, 40.Lin, J. H.; Wei, Z. J.; Chu, P. F. Anal. Biochem. 2012, 421, 97.
Options
Outlines

/

〈 〉